000 01446 a2200433 4500
005 20250517110417.0
264 0 _c20171110
008 201711s 0 0 eng d
022 _a2363-8915
024 7 _a10.1515/dmpt-2016-0006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFalvella, Felicia Stefania
245 0 0 _aPharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen?
_h[electronic resource]
260 _bDrug metabolism and personalized therapy
_c09 2016
300 _a157-63 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAlleles
650 0 4 _aChild
650 0 4 _aCytochrome P-450 CYP2C9
_xgenetics
650 0 4 _aCytochrome P-450 CYP3A
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aLosartan
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMarfan Syndrome
_xdrug therapy
700 1 _aMarelli, Susan
700 1 _aCheli, Stefania
700 1 _aMontanelli, Stefano
700 1 _aViecca, Federico
700 1 _aSalvi, Lucia
700 1 _aFerrara, Alfio
700 1 _aClementi, Emilio
700 1 _aTrifirò, Giuliana
700 1 _aPini, Alessandro
773 0 _tDrug metabolism and personalized therapy
_gvol. 31
_gno. 3
_gp. 157-63
856 4 0 _uhttps://doi.org/10.1515/dmpt-2016-0006
_zAvailable from publisher's website
999 _c26281418
_d26281418